StockNews.com started coverage on shares of Quotient (NASDAQ:QTNT – Get Rating) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock.
Several other analysts have also issued reports on QTNT. Cowen decreased their price target on shares of Quotient from $9.00 to $3.00 and set an outperform rating on the stock in a research report on Wednesday, June 29th. Cowen decreased their price target on shares of Quotient from $9.00 to $3.00 and set an outperform rating on the stock in a research report on Wednesday, June 29th. Finally, BTIG Research decreased their price target on shares of Quotient from $9.00 to $1.50 and set a buy rating on the stock in a research report on Wednesday, June 29th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Quotient has an average rating of Moderate Buy and an average target price of $2.25.
Get
Quotient alerts:
Quotient Stock Performance
Shares of NASDAQ:QTNT opened at $0.19 on Friday. The stock has a market capitalization of $19.84 million, a price-to-earnings ratio of -0.14 and a beta of 2.76. Quotient has a 1-year low of $0.16 and a 1-year high of $3.19. The company has a 50 day moving average price of $0.23 and a 200 day moving average price of $0.49.
Quotient (NASDAQ:QTNT – Get Rating) last posted its quarterly earnings data on Tuesday, August 9th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.09). The company had revenue of $8.81 million for the quarter, compared to analysts' expectations of $9.40 million. On average, sell-side analysts expect that Quotient will post -0.69 EPS for the current fiscal year.
Insider Activity
In other news, Director Zubeen Shroff purchased 4,666,666 shares of Quotient stock in a transaction on Friday, June 24th. The shares were purchased at an average cost of $0.30 per share, for a total transaction of $1,399,999.80. Following the completion of the transaction, the director now directly owns 11,995,740 shares in the company, valued at $3,598,722. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Prondzynski Heino Von purchased 700,000 shares of Quotient stock in a transaction on Thursday, September 15th. The shares were purchased at an average cost of $0.20 per share, for a total transaction of $140,000.00. Following the completion of the transaction, the director now directly owns 1,405,879 shares in the company, valued at $281,175.80. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Zubeen Shroff bought 4,666,666 shares of the company's stock in a transaction on Friday, June 24th. The stock was bought at an average cost of $0.30 per share, with a total value of $1,399,999.80. Following the completion of the purchase, the director now owns 11,995,740 shares of the company's stock, valued at approximately $3,598,722. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 5,718,140 shares of company stock worth $1,615,354. Corporate insiders own 10.50% of the company's stock.
Hedge Funds Weigh In On Quotient
A number of institutional investors have recently modified their holdings of QTNT. JPMorgan Chase & Co. raised its stake in shares of Quotient by 9,156.7% in the second quarter. JPMorgan Chase & Co. now owns 3,491,154 shares of the company's stock worth $838,000 after acquiring an additional 3,453,439 shares during the last quarter. Walleye Capital LLC raised its stake in shares of Quotient by 4,136.3% in the second quarter. Walleye Capital LLC now owns 3,000,000 shares of the company's stock worth $720,000 after acquiring an additional 2,929,184 shares during the last quarter. Highbridge Capital Management LLC raised its stake in shares of Quotient by 24.2% in the first quarter. Highbridge Capital Management LLC now owns 9,117,257 shares of the company's stock worth $10,941,000 after acquiring an additional 1,776,154 shares during the last quarter. Millennium Management LLC bought a new position in shares of Quotient in the second quarter worth about $343,000. Finally, Allianz Asset Management GmbH raised its stake in shares of Quotient by 64.5% during the fourth quarter. Allianz Asset Management GmbH now owns 863,334 shares of the company's stock worth $2,236,000 after buying an additional 338,505 shares during the last quarter. 86.84% of the stock is owned by institutional investors.
About Quotient
(Get Rating)
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening.
Read More
- Get a free copy of the StockNews.com research report on Quotient (QTNT)
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.
